Verve Therapeutics, Inc.

Ownership Transactions Reported by 38 Insiders

Symbol
VERV on Nasdaq
Location
201 Brookline Avenue, Suite 601, Boston, MA

Insiders trading volume in the past year

Verve Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gv 2019 Gp, L.L.C. 10%+ Owner $44.7M Jun 21, 2021
ARCH Venture Partners X, LLC 10%+ Owner $25.1M Jun 21, 2021
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10%+ Owner $25M Jun 21, 2021
Casdin Partners Master Fund, L.P. 10%+ Owner $24.2M Jun 21, 2021
Redmile Group, LLC 10%+ Owner $19.4M Jun 21, 2021
Gv 2023 Gp, L.L.C. Member of 10% Group $18M Dec 1, 2023
Cormorant Asset Management, LP Former 10% Owner $9.84M Jun 21, 2021
Logos Global Management LP 10%+ Owner $8.13M Jun 21, 2021
Broad Institute, Inc. 10%+ Owner $8.1M Jun 21, 2021
Novo Holdings A/S 10%+ Owner $7.93M Jun 21, 2021
Casdin Private Growth Equity Fund, L.P. 10%+ Owner $6.21M Jun 21, 2021
Fmr Llc Other* $5.71M Jul 26, 2022
Beam Therapeutics Inc. 10%+ Owner $5.47M Jun 21, 2021
Israel Rozen 10%+ Owner $4.1M Jun 16, 2021
Barry Ticho 10%+ Owner $4.1M Jun 16, 2021
Jae Keith Joung 10%+ Owner $4.1M Jun 16, 2021
Rock Springs Capital Management LP 10%+ Owner $1.53M Jun 21, 2021
Andrew Bellinger Chief Scientific Officer $450K Feb 14, 2024
Sekar Kathiresan Chief Executive Officer, Director $411K -$40.8K -9.03% Jul 25, 2025
Fred T. Fiedorek Chief Medical Officer $220K Feb 14, 2024
Allison Dorval Chief Financial Officer $140K -$17K -10.8% Jul 25, 2025
Andrew Ashe President, Chief Operating Officer and General Counsel $112K -$11.1K -9.03% Jul 25, 2025
Joan Nickerson Chief Administrative Officer $74.7K -$11.5K -13.4% Jul 25, 2025
Jason Politi Chief Technical Ops. Off. $68.5K -$13.4K -16.4% Jul 25, 2025
Troy Lister Chief Scientific Officer $68.1K -$9.08K -11.8% Jul 25, 2025
Margaret Beaudoin Vice President, Finance $10K Jun 17, 2021
Adelman Burt A Director $0 Jul 25, 2025
Gv 2017 Gp, L.L.C. 10%+ Owner $0 Jul 25, 2025
Krishna Yeshwant Director, 10%+ Owner $0 Jul 25, 2025
Biomatics Capital Partners, L.P. 10%+ Owner Jun 16, 2021
John M. Evans Director Jun 9, 2022
Alexander Cumbo Director Jul 25, 2025
Ourania Tatsis Director Jul 25, 2025
Jodie Pope Morrison Director Jul 25, 2025
Michael F. MacLean Director Jul 25, 2025
ARCH Venture Fund X, L.P. 10%+ Owner Jun 16, 2021
Lonnel Coats Director Jul 25, 2025
Sheila Mikhail Director Jul 25, 2025

Recent Insider Transactions by Companies or Individuals for Verve Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.